LED and microRNA Treatment for AMD Blindness & Other Tissues
Age-Related Macular Degeneration (AMD) Therapies
Tags: Australian National University, Australia, Healthcare & Lifesciences
ANU researchers are developing a therapy for atrophic Age-Related Macular Degeneration (AMD), the leading cause of blindness, using microRNA in extracellular vesicles as a novel treatment. This therapy, derived from a state-of-the-art LED-based model, may also apply to neurodegenerative diseases beyond retinal degeneration. The approach offers a natural delivery system, is multi-targeted, and potentially modifiable for tissue-specific treatments. Its applications span ophthalmology, neurodegeneration therapy, diagnostics, and pharmaceuticals, representing a significant market gap.
IP Type or Form Factor: Platform; Process & Method
TRL: Not specified
Industry or Tech Area: Biotechnology; Healthcare Provider
